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THE AUSTRALASIAN RADIATION PROTECTION SOCIETY’S POSITION
STATEMENT ON RISKS FROM LOW LEVELS OF IONIZING RADIATION
Donald Higson  Paddington, NSW, Australia
 Controversy continues on whether or not ionizing radiation is harmful at low doses,
with unresolved scientific uncertainty about effects below a few tens of millisieverts. To set-
tle what regulatory controls should apply in this dose region, an assumption has to be
made relating dose to the possibility of harm or benefit. The position of the Australasian
Radiation Protection Society on this matter is set out in a statement adopted by the Society
in 2005. Its salient features are:
• There is insufficient evidence to establish a dose-effect relationship for doses that
are less than a few tens of millisieverts in a year. A linear extrapolation from higher
dose levels should be assumed only for the purpose of applying regulatory controls.
• Estimates of collective dose arising from individual doses that are less than some
tens of millisieverts in a year should not be used to predict numbers of fatal cancers.
• The risk to an individual of doses significantly less than 100 microsieverts in a year
is so small, if it exists at all, that regulatory requirements to control exposure at
this level are not warranted.
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INTRODUCTION
At its Annual General Meeting in 2004, the Australasian Radiation
Protection Society (ARPS) set up a Working Group to draft a statement
of the Society’s position on risks from exposure to low level radiation. To
carry out this task, the ARPS Executive Committee established the mem-
bership of this Working Group, as follows:
Dr Riaz Akber, 
Mr Peter Burns, 
Dr Donald Higson, 
Dr Ches Mason, 
Dr Andrew McEwan and 
Dr Pamela Sykes
The Working Group was assisted by two of the office bearers of the
Society: 
Dr Ron Cameron and 
Dr Joe Young. 
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All those who participated in this work did so as private individuals
and not as representatives of any organisation other than ARPS. 
The Position Statement is appended (Appendix 1). It does not pur-
port to be a comprehensive review of the scientific literature. Rather, it
represents a consensus of the expert views of members of the group.
Nevertheless, it is considered to be consistent with scientifically based
information on the biological effects of ionising radiation. A list is provid-
ed of references to some of the key publications considered by the group.
KEY FEATURES OF THE SCIENTIFIC LITERATURE
A number of key features of the scientific literature were noted, as
follows:
1. Experiments in radiation biology have shown that damage caused by
radiation to DNA in living cells could be an initiating event in the de-
velopment of cancer in exposed persons and hereditary effects in
their descendants. This observation, and the assumption that the risk
of radiation induced cancer is proportional to dose without a thresh-
old (the LNT model), underpin current radiation protection practice
and reflect the considered views of the United Nations Scientific Com-
mittee on the Effects of Atomic Radiation (UNSCEAR) and the In-
ternational Commission on Radiological Protection (ICRP).
2. Radiation exposure can also induce or activate cellular DNA protec-
tive capacity involving damage prevention, repair and removal, addi-
tional to that which would otherwise exist. This “adaptive response”
to radiation may reduce the effects of damage from radiation or from
other causes.
3. The effects and responses, described in 1 and 2 above, are not nec-
essarily confined to the cell which is hit by a radiation track. A cell
which is hit can interact with neighbouring cells by intercellular com-
munication systems, thus involving inter alia defence mechanisms in
the tissue and organ as well as in the cell.
4. Experiments with irradiation of animals have shown that the
enhancement of protective capacity, described in 2 above, can pre-
dominate over detrimental effects at low levels of radiation exposure.
Such an effect, sometimes called “radiation hormesis”, has been
observed in cells from virtually all types of organisms, in whole plants
and animal species other than humans, and in human cells. For doses
greater than about 100 mSv in animals, it has been observed that
detrimental effects may dominate. 
5. Hence, both bio-positive and bio-negative effects of radiation might
be expected in humans. At low levels of exposure, the net effect may
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6. The human race (as it now exists) represents only the small, success-
ful part of all the trials and errors of evolution, which has occurred
in the presence of ionizing radiation and many other agents that are
harmful at high levels of exposure, including sunlight, heavy metals
in food and water, arsenic and various naturally-occurring chemical
compounds. Levels of these agents in our environment have varied
from place to place and from time to time during the evolution of life
on earth. It is a fundamental tenet of evolutionary biology that organ-
isms adapt to their environment. Hence, it might be expected that a
normal level of exposure to these agents would be necessary for life
and normal health; that small increases above the normal level might
be beneficial although large increases would be harmful. The bene-
ficial effect from small increases in exposure to environmental agents
occurs widely in nature and is called “hormesis”. There is no such
thing as a toxic agent – only toxic doses. Calabrese and Baldwin
(2003) have concluded that “the hormetic model is not the excep-
tion to the rule – it is the rule”.
7. Human epidemiology has shown that acute doses greater than about
100 mSv can cause increases in the incidence of cancer. For acute
doses less than a few tens of millisieverts and for low dose rates, there
is often a lack of statistical significance to any health effect of radia-
tion. Studies are confounded by many factors including diet and
smoking, which can have much greater effects on the incidences of
cancer than radiation. Smoking is a powerful confounding factor in
epidemiology related to many forms of cancer, not just lung cancer. 
8. There is no significant discernable effect of natural background radi-
ation on the incidences of cancer or genetic damage, although the
background dose rate ranges around the world from less than 1 mSv
per year to more than 100 mSv per year in a few areas. Lifetime doses
from natural radiation range up to thousands of millisieverts.
Populations exposed to very high dose rates for long periods, and for
many generations, may be too small for reliable statistically based
conclusions to be drawn. Nevertheless, it can reasonably be said that
harm has not been found to result from exposures to chronic dose
rates up to at least a few tens of millisieverts per year.
9. Many studies have been conducted of the possible risk of lung cancer
due to radon in homes. Results range from positive to negative cor-
relations, possibly inter alia because of the confounding effect of
smoking. Recent studies of pooled data suggest a linear relation
between excess relative risk and radon exposure down to less than 5
mSv/y, with significant uncertainties. A conclusion which can be
drawn from one such study, by Darby et al (2005), is that the absolute
risk of lung cancer from radon is predominantly a risk to smokers,
apparently compounded by the synergistic effect of radon. Without
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smoking, the reported risk from radon (up to at least 20 mSv/y) is
small compared with other causes.
10. The effects of low dose exposure to external radiation have been esti-
mated in several cohorts of workers in the nuclear industry, but the
sample sizes have limited the significance of these estimates.
Estimates from these analyses are compatible with a range of possi-
bilities, from a reduction of risk to risks higher than those underlying
current radiation protection recommendations. Again, smoking is a
powerful confounding factor. The study of pooled data by Cardis et
al (2005) has concluded that “a small excess risk of cancer exists,
even at the low doses typically received by nuclear industry workers
in this study”. However, a careful examination of the published
report leaves room for some doubt on the inferences that may be
drawn from it. For example, without the inclusion of Canadian data,
which show unusually high (and unexplained) cancer mortality, the
findings of Cardis et al appear to be statistically insignificant.
11. The only confirmed health effects of radiation from the Chernobyl
reactor accident in 1986 have been associated with very high doses to
workers, who were at the plant at the time and immediately following
the accident, and to the thyroids of children in some districts around
Chernobyl. About 100,000 workers and many members of the public
were exposed to doses in excess of 100 mSv. There has been no dis-
cernible increase in the incidence of cancers, other than child thy-
roid cancer, but it may be too early to draw firm conclusions about
the development of solid tumours with minimum latency periods of
10-20 years. The incidence of leukaemia was one of the main con-
cerns, due to its short latency period (5-10 years after radiation expo-
sure in adults). No increase has been observed in the incidence of
leukaemia in any of the exposed groups.
12. Major reviews of literature on the biological effects of radiation, pub-
lished by Brenner et al (2003) and the BEIR VII Committee of the Na-
tional Research Council of the National Academies (2005), and in
draft documents posted on the ICRP website in 2005, have endorsed
the assumption of the LNT model. However, they do not refer to im-
portant evidence that conflicts with the LNT assumption. The authors
of these reviews may have good reasons for dismissing such evidence
but, without a considered analysis, it is difficult to understand and
concur with their conclusions.
The Working Group’s attention was drawn to reports concerning
more than 180 apartment buildings, constructed in Taiwan more than 20
years ago using reinforcing bars contaminated with cobalt-60 (apparently
from an orphaned source, which had been inadvertently recycled through
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incurred an average dose of about 400 mSv from the cobalt-60, some of
them being exposed initially to dose rates greater than 500 mSv/y. Chen
et al (2004) have reported dramatic reductions in the overall incidences of
cancers and hereditary defects amongst these residents – by factors of
more than ten below the numbers which would be expected for an unex-
posed population. This extraordinary incident and report have attracted
little independent analysis by other authors and seem to have had essen-
tially no impact on the theory or practice of radiation protection.
REACHING CONSENSUS AND ADOPTION OF THE STATEMENT
Beyond the agreement that was reached on points 1 to 12 above,
opinions within the Working Group ranged widely on all other issues dis-
cussed. Significant compromises were necessary to reach a consensus on
the wording of the Statement. The resulting document, entitled “ARPS
Position Statement on Risks from Exposure to Low Levels of Ionizing
Radiation” (Appendix 1), was circulated to ARPS members and was
adopted by the Society at its Annual General Meeting held in Melbourne,
on 14 November 2005.
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APPENDIX 1. THE ARPS POSITION STATEMENT 
(ADOPTED 14 NOVEMBER 2005)
Controversy continues in the radiation protection literature on
whether or not ionizing radiation is harmful at very low doses. There is
scientific uncertainty about the dose-effect relationship below a few tens
of millisieverts in a year, and in order to settle what regulatory controls, if
any, should apply in this dose region an assumption has to be made relat-
ing dose to the possibility of harm or benefit. The assumption made and,
more particularly, the way it is applied can have far-reaching effects not
only on the scale of regulatory compliance required but also on public
perception of risk and therefore on the technological choices made by
society. It is important therefore that decisions reached concerning regu-
lation of low doses of ionizing radiation have an ethical basis and derive
from rational argument. It is also important that such decisions are nei-
ther portrayed nor perceived as resolving the scientific uncertainties:
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Following a review of available information, the Australasian
Radiation Protection Society has adopted the following position. Based
on the features observed, the range of exposures has been divided into
three broad dose groups, but it should be noted that the boundaries
between them are not known with precision.
Doses above about 10 mSv in a year
• There is strong epidemiological evidence that acute exposure to ioniz-
ing radiation of more than about 100 mSv carries a risk of developing
fatal cancer that increases with dose, with some limited evidence sup-
porting a risk at slightly lower doses. There are also epidemiological
reports of statistically significant risk from long-term cumulative expo-
sures that correspond to doses received at rates down to a few mil-
lisieverts in a year, but it is difficult to be confident that the observed
effects can be reliably separated from possible confounding factors.
• In the light of the above, for the purpose of applying regulatory con-
trols to radiation protection when effective doses exceed a few tens of
millisieverts in a year, it is reasonable to assume a generalized risk coef-
ficient for fatal cancer of 1 in 20 per sievert for a population of all ages,
as recommended by the International Commission on Radiological
Protection [ICRP Publication 60]. This assumption is less reliable for
exposures below 100 mSv in a year than above.
• Consistent with this assumption, an effective dose limit for occupational
exposure of 20 mSv per year, averaged over 5 years and no more than
50 mSv in any one year, remains appropriate, as does a requirement to
optimize protection below this value. Separately, safety measures are re-
quired to avoid deterministic effects of radiation at very high doses.
Doses between about 0.1 and about 10 mSv in a year
• There is insufficient epidemiological evidence to establish a dose-effect
relationship for effective doses of less than a few tens of millisieverts in
a year above the background level of exposure. It is possible that both
an adverse effect, through causation of cancer following radiation dam-
age to DNA, and a beneficial effect, through stimulation of repair
mechanisms, may operate. It has also been speculated that such a stim-
ulatory effect might reduce mortality from cancer caused by agents
other than radiation, resulting in a net decrease in risk. Consequently,
neither harmful nor beneficial effects can be ruled out.
• To put doses in this range into perspective, it is worth noting that the
worldwide average exposure to natural radiation sources is estimated
by the United Nations Scientific Committee on the Effects of Atomic
Radiation to be 2.4 mSv in a year, with a typical range of 1 to 10 mSv in
a year. There are a few areas of the world where much higher doses are
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received from naturally-occurring sources without causing discernible
risks to health.
• Taking an ethical position of caution in the face of uncertainty, the risk
coefficient adopted above for higher doses may be used for the purpose
of establishing control measures for exposure to radiation at lower
doses. In particular, the use of an effective dose limit of 1mSv in a year
for members of the public is appropriate for exposure caused by the
conduct of business activities. This limit will ensure that the additional
risk of harm, if any, arising from such activities is acceptably small. How-
ever, no inference may be drawn concerning the risk to health or risk of
fatality of an individual from an effective dose below 10 mSv in a year.
For individual doses less than some tens of millisieverts in a year, risk in-
ferences are unreliable and carry a large uncertainty that includes the
possibility of zero risk.
Doses below about 0.1 mSv in a year
• The risk to an individual of doses less than a few hundredths of a mil-
lisievert in a year is so small, if it exists at all, that regulatory require-
ments to control exposure at this level are not warranted. Business ac-
tivities causing individual effective doses of the order of 0.01 mSv in a
year or less should be automatically exempted from regulatory control,
provided that the activity is inherently safe: that is, there is little likeli-
hood of accidents leading to significantly higher doses. Activities caus-
ing levels of exposure up to 0.1 mSv in a year may also be exempted if
the regulatory body determines that the application of controls is not
warranted, taking into account all relevant factors. In deciding whether
control measures are warranted, or how stringent they should be, regu-
latory bodies should have in mind, inter alia, the principle that societal
resources should not be wasted or freedoms inhibited through manda-
tory observance of unnecessary regulatory controls.
Collective dose
• Estimates of collective dose to groups or to populations should be used
with caution. In view of the uncertain association between low doses
and risk, estimates of collective dose arising from individual doses that
are less than some tens of millisieverts in a year should not be used to
predict numbers of fatal cancers for the exposed group or population.
• However, if collective doses to subgroups of an exposed population are
each assigned an appropriate weight, they may play a role in making a
choice between possible control measures and thus in optimizing pro-
tection. The component of collective dose arising from the summation
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signed little significance relative to components associated with sub-
groups receiving higher doses, and the component associated with
doses less than some hundredths of a millsievert in a year may be as-
signed a weight of zero. Various values for this cut-off have been pro-
posed, from 0.01 to 0.1 mSv.
What is ‘safe’?
• The word ‘safe’ may be used to describe business activities that meet
currently prescribed radiation safety standards. While there may be
some, as yet uncertain, risk arising from such activities, it is known to
be small at most and, through application of the justification principle,
to be outweighed by the benefits brought by the activity. It follows that
exposures of this order may be described as ‘safe’, understanding that
the word is used not in an absolute sense but with the meaning of caus-
ing an acceptably small risk, if any.
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